Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

Systemic treatment with the active transcription inhibitor lurbinectedin aims at inducing tumor cell death in hyperproliferative neoplasms. Here we show that cell death induced by lurbinectedin reinstates and enhances systemic anticancer immune responses. Lurbinectedin treatment showed traits of imm...

Полное описание

Библиографические подробности

Главные авторы:	Wei Xie, Sabrina Forveille, Kristina Iribarren, Allan Sauvat, Laura Senovilla, Yan Wang, Juliette Humeau, Maria Perez-Lanzon, Heng Zhou, Juan F. Martínez-Leal, Guido Kroemer, Oliver Kepp
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2019-11-01
Серии:	OncoImmunology
Предметы:	anticancer immunity immunogenic cell death checkpoint blockade tumor clearance
Online-ссылка:	http://dx.doi.org/10.1080/2162402X.2019.1656502
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!